When cure becomes an illness-Abuse of addictive prescription medicines

Frontiers in Pharmacology

Volumn 6, Issue SEP, 2015, Pages

  Jakovljevic, Mihajlo ^a   Lazarevic, Marija ^a   Jurisevic, Milena ^a   Jovanovic, Mirjana R ^a,b  

^a University of Kragujevac Medical Faculty   (Serbia)

^b University Clinical Center Kragujevac   (Serbia)

Author keywords

Addiction; Costs; Drugs of abuse; Expenditure; Pharmaceutical market; Trend

Indexed keywords

ANESTHETIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; NOOTROPIC AGENT; OPIATE; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT;

DRUG INDUSTRY; DRUG MARKETING; DRUG USE; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; NOTE; PRESCRIPTION; PUBLIC HEALTH; QUALITY OF LIFE; REIMBURSEMENT; SERBIA; SUBSTANCE ABUSE;

EID: 84944749831     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00193     Document Type: Note

References (31)

1. Agencija za lekove i medicinska sredstva Srbije. (2013). Promet i Potrosnja Gotovih Lekovaza Humanu u potrebu u Republici Srbijiu 2012. Godini. Beograd: Helicon Publishing. Available online at: http://www.alims.gov.rs/ciril/files/2014/09/PROMET_javnost-2012.pdf
2. Babor, T. F., McRee, B. G., Kassebaum, P. A., Grimaldi, P. L., Ahmed, K., and Bray, J. (2007). Screening, Brief Intervention, and Referral to Treatment (SBIRT) toward a public health approach to the management of substance abuse. Subst. Abus. 28, 7-30. doi: 10.1300/J465v28n03_03
3. Bendtsen, P., Hensing, G., McKenzie, L., and Stridsman, A. K. (1999). Prescribing benzodiazepines a critical incident study of a physician dilemma. Soc. Sci. Med. 49, 459-467. doi: 10.1016/S0277-9536(99)00133-1
4. Compton, W. M., and Volkow, N. D. (2006). Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 83, S4-S7. doi: 10.1016/j.drugalcdep.2005.10.020
5. Divac, N., Jašovic, M., Djukic, L., Vujnovic, M., Babic, D., Bajcetic, M., et al. (2004). Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol. Drug Saf. 13, 315-322. doi: 10.1002/pds.940
6. Divac, N., Todorovic, Z., Stojanovic, R., Nesic, Z., Jasovic-Gasic, M., Lecic-Tosevski, D., et al. (2009). Utilization of psychiatric drugs in Serbia. Vojnosanit. Pregl. 66, 233-237. doi: 10.2298/VSP0903233D
7. European School Survey Project on Alcohol and Other Drugs (ESSPAD). (2008). EvropskoistraŽivanje o upotrebialkoholaidrugihdrogameğumladima u Srbiji, 2008. Belgrade: Ministry of Health of the Republic of Serbia, Institute of Public Health of Serbia, "DrMilanJovanovic-Batut."
8. Getzen, T. E. (1990). Macro forecasting of national health expenditures. Adv. Health Econ. Health Serv. Res. 11, 27.
9. Hashemi, S., and Hashemi, S. A. R. A. (2015). Effectiveness of group cognitive behavioral intervention to increase perceived social support in patients with substance abuse (a treatment model in prevention of substance abuse). Eur. Psychiatry 30, 1101. doi: 10.1016/s0924-9338(15)30869-5
10. Inciardi, J. A., Surratt, H. L., Kurtz, S. P., and Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Med. 8, 171-183. doi: 10.1111/j.1526-4637.2006.00255.x
11. Jakovljevic, M. B. (2013). Resource allocation strategies in Southeastern European health policy. Eur. J. Health Econ. 14, 153-159. doi: 10.1007/s10198-012-0439-y
12. Jakovljevic, M. B. (2014). Health Expenditure Dynamics in Serbia 1995-2012, Hospital Pharmacology. Int. Multidiscipli. J. 1, 180-183.
13. Jakovljevic, M., and Laaser, U. (2015). Population aging from 1950 to 2010 in seventeen transitional countries in the wider region of South Eastern Europe (Original research). SEEJPH. doi: 10.12908/SEEJPH-2014-42 [Epub ahead of print].
14. Jakovljevic, M., Djordjevic, N., Jurisevic, M., and Jankovic, S. (2015a). Evolution of Serbian pharmaceutical market alongside socioeconomic transition. Expert Rev. Pharmacoecon. Outcomes Res. 15, 521-530. doi: 10.1586/14737167.2015.1003044
15. Jakovljevic, M., Jovanovic, M., Lazic, Z., Jakovljevic, V., Djukic, A., Velickovic, R., et al. (2011). Current efforts and proposals to reduce healthcare costs in Serbia. Ser. J. Exp. Clin. Res. 12, 161-310. doi: 10.5937/sjecr1104161J
16. Jakovljevic, M., Jovanovic, M., Rancic, N., Vyssoki, B., and Djordjevic, N. (2014). LAT software induced savings on medical costs of alcohol addicts' care-results from a matched-pairs case-control study. PLoS ONE 9:e111931. doi: 10.1371/journal.pone.0111931
17. Jakovljevic, M., Mijailovic, Z., Jovicic, B. P., Canovic, P., Gajovic, O., Jovanovic, M., et al. (2013a). Assessment of viral genotype impact to the cost-effectiveness and overall costs of care for Peg-interferon-2a+ ribavirine treated chronic hepatitis C patients. Hepat. Mon. 13:e6750. doi: 10.5812/hepatmon.6750
18. Jakovljevic, M., Riegler, A., Jovanovic, M., Djordjevic, N., Patek, K., Lesch, O., et al. (2013b). Serbian and Austrian alcohol-dependent patients: a comparison of two samples regarding therapeutically relevant clinical features. Alcohol Alcohol. 48, 505-508. doi: 10.1093/alcalc/agt011
19. Jakovljevic, M., Vukovic, M., Chia-Ching, C., Antunovic, M., Dragojevic-Simic, V., Velickovic-Radovanovic, R., et al. (2015b). Do health reforms impact cost consciousness of Health care professionals? Results from a nation-wide survey in the Balkans. Balkan Med. J. doi: 10.5152/balkanmedj.2015.15869 [Epub ahead of print].
20. Jovanovic, M., and Jakovljevic, M. (2011). Inpatient detoxification procedure and facilities: financing considerations from an Eastern European perspective. Alcohol Alcohol. 46, 364-365. doi: 10.1093/alcalc/agr010
21. Khan, M., Saeed, R., Sujjat, J., Mukhtar, Z., and Naiz, S. (2015). Preventive strategies for medically induced drug addiction. Eur. Psychiatry 30, 1070. doi: 10.1016/s0924-9338(15)30844-0
22. Kilibarda, B., Kilibarda, B., Mravcik, V., Sieroslawski, J., Rakic, J. G., and Martens, M. S. (2014). National Survey on Life Styles of Citizen in Serbia 2014:Key Findings on Substance use and Gambling. Beograd: Institute of Public Health of Serbia.
23. Lessenger, J. E., and Feinberg, S. D. (2008). Abuse of prescription and over-the-counter medications. J. Am. Board Fam. Med. 21, 45-54. doi: 10.3122/jabfm.2008.01.070071
24. Miljkovic, M., and Djukic, L. J. (2000). Analysis of drug utilization in Serbia during the years 1996 and 1997. Pharmacoepidemiol. Drug Saf. 9, 59-64. doi: 10.1002/(SICI)1099-1557(200001/02)9:1%3C59
25. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 264, 2511-2518. doi: 10.1001/jama.1990.03450190043026
26. Ristic-Ignjatovic, D., Hinic, D., Jakovljevic, M., Fountoulakis, K., Siapera, M., and Rancic, N. (2013). A ten-year study of depressive symptoms in Serbian medical students. Acta Clin. Croat. 52, 157-164.
27. Sj�qvist, F., and Birkett, D. (2003). Drug Utilization. Introduction to Drug Utilization Research. Geneva: WHO.
28. United Nations Office on Drugs and Crime. (2010). World Drug Report 2010. New York, NY: United Nations Publications.
29. Vukovic, M., Gvozdenovic, B. S., Rankovi�, M., McCormick, B. P., Vukovic, D. D., Gvozdenovic, B. D., et al. (2015). Can didactic continuing education improve clinical decision making and reduce cost of quality? Evidence from a case study. J. Contin. Educ. Health Prof. 35, 109-118. doi: 10.1002/chp.21272
30. Wolde, G., Dijkstra, A., Empelen, P., Neven, A., and Zitman, F. (2008). Psychologial determinants of the intentions to educate patients about benzodiazepines. Pharm. World Sci. 30, 336-342. doi: 10.1007/s11096-007-9183-2
31. Yamada, T., Kendix, M., and Yamada, T. (1993). The Impact of Alcohol Consumption and Marijuana use on High School Graduation (No. w4497). New York, NY: National Bureau of Economic Research.